Antipsychotic Medication for Older Individuals
JAMA Network Open · 25.03.2026 · 9 (3) · e263434
DOI: 10.1001/jamanetworkopen.2026.3434 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 25.03.2026. Verfasst von James S Goodwin. Beteiligte Einrichtung: Sealy Center on Aging, Department of Internal Medicine, Division of Geriatrics, University of Texas Medical Branch at Galveston. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kim and colleagues 1 use Medicare Part D data to describe the temporal patterns from 2013 to 2023 in the use of antipsychotic medications, with a focus on the discipline of the clinician listed on the prescription.They show that the share of such prescriptions issued by psychiatrists decreased from 48.4% in 2013 to 32.4% in 2023 and that the share by primary care physicians (PCPs) decreased from 33.0% to 23.8%.In contrast, the share of antipsychotic prescriptions written by advanced practice registered nurses (APRNs) or physician assistants (PAs) increased from 13.8% in 2013 to 39.6% in
Autor:innen und Institutionen
- Sealy Center on Aging, Department of Internal Medicine, Division of Geriatrics, University of Texas Medical Branch at Galveston.
Zitieren
APA
Goodwin, J. S. (2026). Antipsychotic Medication for Older Individuals. JAMA Network Open, 9(3), e263434. https://doi.org/10.1001/jamanetworkopen.2026.3434
Vancouver
Goodwin JS. Antipsychotic Medication for Older Individuals. JAMA Network Open. 2026;9(3):e263434. doi:10.1001/jamanetworkopen.2026.3434
BibTeX
@article{Goodwin2026,
author = {Goodwin, James S},
title = {Antipsychotic Medication for Older Individuals},
journal = {JAMA Network Open},
year = {2026},
volume = {9},
number = {3},
pages = {e263434},
doi = {10.1001/jamanetworkopen.2026.3434}
}
EUVIMED